Magnetic resonance imaging of nasopharyngeal carcinoma

References

• Chan AT, Teo PM, Johnson PJ. Nasopharyngeal carcinoma. Ann. Oncol.13(7), 1007–1015 (2002).
   PubMed Web of Science ®Google Scholar
• Chong VFH. Neoplasms of the nasopharynx. In: Head and Neck Cancer Imaging. Baert AL, Sartor K (Eds). Springer, Berlin, Germany, 143–162 (2006).
   Google Scholar
• Henderson BE, Louie E, SooHoo Jing J, Buell P, Gardner MB. Risk factors associated with nasopharyngeal carcinoma. N. Engl. J. Med.295(20), 1101–1106 (1976).
   PubMed Web of Science ®Google Scholar
• Yu MC, Mo CC, Chong WX et al. Preserved foods and nasopharyngeal carcinoma: a case–control study in Guangxi, China. Cancer Res.48, 1954–1959 (1988).
   PubMed Web of Science ®Google Scholar
• Vasef MA, Ferlito A, Weiss LM. Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein–Barr virus. Ann. Otol. Rhinol. Laryngol.106(4), 348–356 (1997).
   PubMedGoogle Scholar
• Ren EC, Chan SH. Human leucocyte antigens and nasopharyngeal carcinoma. Clin. Sci. (Lond.)91(3), 256–258 (1996).
   PubMedGoogle Scholar
• Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S. Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int. J. Cancer77(2), 228–235 (1998).
   PubMed Web of Science ®Google Scholar
• Goh J, Lim K. Imaging of nasopharyngeal carcinoma. Ann. Acad. Med. Singapore38(9), 809–816 (2009).
   PubMedGoogle Scholar
• Comoretto M, Balestreri L, Borsatti E, Cimitan M, Franchin G, Lise M. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Radiology249(1), 203–211 (2008).
   PubMedGoogle Scholar
• Sanguineti G, Geara FB, Garden AS et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int. J. Radiat. Oncol. Biol. Phys.37(5), 985–996 (1997).
   PubMed Web of Science ®Google Scholar
• Geara FB, Sanguineti G, Tucker SL et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother. Oncol.43(1), 53–61 (1997).
   PubMed Web of Science ®Google Scholar
• Ho HC, Lee MS, Hsiao SH et al. Prognostic influence of parapharyngeal extension in nasopharyngeal carcinoma. Acta Otolaryngol.128(7), 790–798 (2008).
   PubMed Web of Science ®Google Scholar
• Lee AW, Tung SY, Chan AT et al. Preliminary results of a randomized study (NPC-9902 trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys.66(1), 142–151 (2007).
   Google Scholar
• Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int. J. Radiat. Oncol. Biol. Phys.57(1), 49–60 (2003).
   PubMed Web of Science ®Google Scholar
• Lee N, Harris J, Garden AS et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group Phase II trial 0225. J. Clin. Oncol.27(22), 3684–3690 (2009).
   PubMed Web of Science ®Google Scholar
• Al-Sarraf M, LeBlanc M, Giri PG et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J. Clin. Oncol.16(4), 1310–1317 (1998).
   PubMed Web of Science ®Google Scholar
• Wee J, Tan EH, Tai BC et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J. Clin. Oncol.23(27), 6730–6738 (2005).
   PubMed Web of Science ®Google Scholar
• Ma BB, Hui EP, Chan AT. Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions. Cancer Sci.99(7), 1311–1318 (2008).
   PubMed Web of Science ®Google Scholar
• Tham IW, Hee SW, Yeo RM et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy – the national cancer centre singapore experience. Int. J. Radiat. Oncol. Biol. Phys.75(5), 1481–1486 (2009).
   PubMed Web of Science ®Google Scholar
• Danesi G, Zanoletti E, Mazzoni A. Salvage surgery for recurrent nasopharyngeal carcinoma. Skull Base17(3), 173–180 (2007).
   PubMedGoogle Scholar
• King AD, Teo P, Lam WW, Leung SF, Metreweli C. Paranasopharyngeal space involvement in nasopharyngeal cancer: detection by CT and MRI. Clin. Oncol. (R. Coll. Radiol.)12(6), 397–402 (2000).
   PubMed Web of Science ®Google Scholar
• Mukherji SK. Pharynx. In: Head and Neck Imaging (Fourth Edition). Som PM, Curtin HD, (Eds). Mosby, St Louis, MO, USA, 1465–1520 (2003).
   Google Scholar
• Mao YP, Xie FY, Liu LZ et al. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys.73(5), 1326–1334 (2009).
   PubMed Web of Science ®Google Scholar
• King AD, Lam WW, Leung SF, Chan YL, Teo P, Metreweli C. MRI of local disease in nasopharyngeal carcinoma: tumour extent vs tumour stage. Br. J. Radiol.72(860), 734–741 (1999).
   PubMedGoogle Scholar
• King AD, Vlantis AC, Tsang RK et al. Magnetic resonance imaging for the detection of nasopharyngeal carcinoma. Am. J. Neuroradiol.27(6), 1288–1291 (2006).
   PubMedGoogle Scholar
• Ng SH, Chang TC, Ko SF et al. Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology39(10), 741–746 (1997).
   PubMedGoogle Scholar
• Liang SB, Sun Y, Liu LZ et al. Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging: improvement of clinical target volume delineation. Int. J. Radiat. Oncol. Biol. Phys.75(3), 742–750 (2009).
   PubMedGoogle Scholar
• Olmi P, Fallai C, Colagrande S, Giannardi G. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. Int. J. Radiat. Oncol. Biol. Phys.32(3), 795–800 (1995).
   PubMedGoogle Scholar
• Chung NN, Ting LL, Hsu WC, Lui LT, Wang PM. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck26(3), 241–246 (2004).
   PubMed Web of Science ®Google Scholar
• Chang JT, Lin CY, Chen TM et al. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.63(5), 1354–1360 (2005).
   PubMed Web of Science ®Google Scholar
• Chong VF, Fan YF, Khoo JB. Nasopharyngeal carcinoma with intracranial spread: CT and MR characteristics. J. Comput. Assist. Tomogr.20(4), 563–569 (1996).
   PubMedGoogle Scholar
• Lau KY, Kan WK, Sze WM et al. Magnetic resonance for T-staging of nasopharyngeal carcinoma – the most informative pair of sequences. Jpn J. Clin. Oncol.34(4), 171–175 (2004).
   PubMedGoogle Scholar
• Som PM, Brandwein MS. Lymph nodes. In: Head and Neck Imaging (Fourth Edition). Som PM, Curtin HD (Eds). Mosby, St Louis, MO, USA, 1865–1934 (2003).
   Google Scholar
• Staging of nasopharyngeal carcinoma: suggestions for improving the current UICC/AJCC Staging System. In: 7th Edition of the International Union Against Cancer (UICC) Manual. Springer (2010).
   Google Scholar
• Lee AW, Au JS, Teo PM et al (Eds). Clin. Oncol. (R. Coll. Radiol.)16(4), 269–276 (2004).
   PubMedGoogle Scholar
• Liu MZ, Tang LL, Zong JF et al. Evaluation of sixth edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement. Int. J. Radiat. Oncol. Biol. Phys.70(4), 1115–1123 (2008).
   PubMedGoogle Scholar
• Chin SC, Fatterpekar G, Chen CY, Som PM. MR imaging of diverse manifestations of nasopharyngeal carcinomas. Am. J. Roentgenol.180(6), 1715–1722 (2003).
   PubMedGoogle Scholar
• Teo P, Lee WY, Yu P. The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma. Radiother. Oncol.39(3), 209–221 (1996).
   PubMed Web of Science ®Google Scholar
• Chua DT, Sham JS, Kwong DL, Choy DT, Au GK, Wu PM. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis. Cancer78(2), 202–210 (1996).
   PubMed Web of Science ®Google Scholar
• Som PM, Curtin HD. Parapharyngeal and masticator space lesions. In: Head and Neck Imaging (fourth edition). Som PM, Curtin HD (Eds). Mosby, St Louis, MO, USA, 1954–2004 (2003).
   Google Scholar
• King AD, Ahuja AT, Leung SF et al. Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck22(3), 275–281 (2000).
   PubMed Web of Science ®Google Scholar
• King AD, Tse GM, Ahuja AT et al. Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and US. Radiology230(3), 720–726 (2004).
   PubMedGoogle Scholar
• Teo PM, Kwan WH, Lee WY, Leung SF, Johnson PJ. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer77(12), 2423–2431 (1996).
   PubMed Web of Science ®Google Scholar
• Kumar MB, Lu JJ, Loh KS et al. Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys.58(3), 688–693 (2004).
   PubMedGoogle Scholar
• Chiesa F, De Paoli F. Distant metastases from nasopharyngeal cancer. ORL J. Otorhinolaryngol. Relat. Spec.63(4), 214–216 (2001).
   PubMedGoogle Scholar
• Chen YK, Su CT, Ding HJ et al. Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients. Anticancer Res.26(2B), 1471–1477 (2006).
   PubMedGoogle Scholar
• Chua ML, Ong SC, Wee JT et al. Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma. Head Neck31(3), 346–354 (2009).
   PubMedGoogle Scholar
• Ng SH, Chan SC, Yen TC et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. Eur. J. Nucl. Med. Mol. Imaging36(1), 12–22 (2009).
   PubMedGoogle Scholar
• Liu FY, Lin CY, Chang JT et al.18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma. J. Nucl. Med.48(10), 1614–1619 (2007).
   PubMedGoogle Scholar
• King AD, Yeung DK, Ahuja AT, Leung SF, Tse GM, van Hasselt AC. In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma. Am. J. Neuroradiol.25(3), 484–490 (2004).
   PubMedGoogle Scholar
• Khawar A, Rafique MA, Jafri RA, Saeed S. Role of Tc99m MIBI SPECT in the assessment of treatment response in pharyngeal carcinoma. Ann. NY Acad. Sci.1138, 50–57 (2008).
   PubMedGoogle Scholar